Alanna M. Chamberlain, Ph.D., is an epidemiologist whose research focuses on outcomes among patients with cardiovascular disease. Dr. Chamberlain is specifically interested in assessing the impact of treatment, clinical characteristics, physical and mental functions, and psychosocial constructs on survival, health care utilization, and onset of adverse outcomes among patients with atrial fibrillation, heart failure, acute coronary syndromes, or a combination of these cardiovascular diseases.
Dr. Chamberlain also has research interests in aging, including large population-based studies on the impact of multimorbidity and frailty on functional status, health care utilization and survival in older adults.
Dr. Chamberlain is the scientific manager of the Rochester Epidemiology Project, a comprehensive medical records linkage system for patients residing in Olmsted County, Minnesota, whereby health care information from virtually all sources of care in the county is captured. In addition, Dr. Chamberlain is a member of the Population Health Science Program in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery.
- Describing trends in cardiovascular disease occurrence such as atrial fibrillation, heart failure and acute coronary syndromes, as well as trends in adverse outcomes associated with these cardiovascular diseases
- Describing treatment patterns in patients with cardiovascular disease, patient characteristics associated with different treatment approaches, and how treatment approaches influence outcomes in real-world settings, where treatment is not randomized
- Assessing the impact of multimorbidity on outcomes in patients with atrial fibrillation or heart failure
- Assessing factors associated with frailty and declining functional status, and determining how changes in frailty and functional status influence outcomes in patients with cardiovascular disease as well as the general population of older adults
Significance to patient care
Utilizing large, population-based research studies, Dr. Chamberlain aims to provide a better understanding of determinants of cardiovascular diseases and outcomes. This research will inform models of patient-centered care and may be used to design more-effective interventions to manage patients with cardiovascular disease and improve outcomes in these patients.
- Academic editor, PLOS ONE, 2014-present
- Peer reviewer, Innovative Research Grant, Clinical and Population Science, American Heart Association, 2014-present
- Member, Institutional Review Board, Olmsted Medical Center, 2014-present